CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 170 enrolled
Drug / intervention
Choosing to receive the vaccineother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01483378
NCT01483378N/ACompleted
CompareCT.gov

Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital

NYU Langone Health·interventional·Posted Dec 1, 2011·Updated Aug 9, 2013

In Brief

A clinical study evaluating Choosing to receive the vaccine for Herpes Zoster. Completed, enrolled 170 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine if vaccination rate of eligible patients at a major urban public hospital will increase by having ophthalmologists screen patients for eligibility and a nurse administer the vaccine in the General Eye Clinic.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHerpes Zoster
CountriesUnited States
CollaboratorsMerck Sharp & Dohme LLC

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedDec 1, 2011
Enrollment StartJan 1, 2012
Primary CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 14.6 years ago

Interventions

Choosing to receive the vaccineother